Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla

Rationale Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of br...

Full description

Bibliographic Details
Main Authors: Godlewska, BR, Williams, S, Emir, UE, Chen, C, Sharpley, AL, Goncalves, AJ, Andersson, MI, Clarke, W, Angus, B, Cowen, PJ
Format: Journal article
Language:English
Published: Springer 2021
_version_ 1826307687334281216
author Godlewska, BR
Williams, S
Emir, UE
Chen, C
Sharpley, AL
Goncalves, AJ
Andersson, MI
Clarke, W
Angus, B
Cowen, PJ
author_facet Godlewska, BR
Williams, S
Emir, UE
Chen, C
Sharpley, AL
Goncalves, AJ
Andersson, MI
Clarke, W
Angus, B
Cowen, PJ
author_sort Godlewska, BR
collection OXFORD
description Rationale Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of brain neurochemicals relevant to aetiological processes that have been linked to CFS, for example, oxidative stress and mitochondrial dysfunction. Methods We studied 22 CFS patients and 13 healthy controls who underwent MRS scanning at 7 T with a voxel placed in the anterior cingulate cortex. Neurometabolite concentrations were calculated using the unsuppressed water signal as a reference. Results Compared to controls, CFS patients had lowered levels of glutathione, total creatine and myo-inositol in anterior cingulate cortex. However, when using N-acetylaspartate as a reference metabolite, only myo-inositol levels continued to be significantly lower in CFS participants. Conclusions The changes in glutathione and creatine are consistent with the presence of oxidative and energetic stress in CFS patients and are potentially remediable by nutritional intervention. A reduction in myo-inositol would be consistent with glial dysfunction. However, the relationship of the neurochemical abnormalities to the causation of CFS remains to be established, and the current findings require prospective replication in a larger sample.
first_indexed 2024-03-07T07:06:51Z
format Journal article
id oxford-uuid:dafb0bd1-f71d-401a-89d7-cbf30e78f929
institution University of Oxford
language English
last_indexed 2024-03-07T07:06:51Z
publishDate 2021
publisher Springer
record_format dspace
spelling oxford-uuid:dafb0bd1-f71d-401a-89d7-cbf30e78f9292022-05-11T11:57:58ZNeurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 TeslaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:dafb0bd1-f71d-401a-89d7-cbf30e78f929EnglishSymplectic ElementsSpringer2021Godlewska, BRWilliams, SEmir, UEChen, CSharpley, ALGoncalves, AJAndersson, MIClarke, WAngus, BCowen, PJRationale Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of brain neurochemicals relevant to aetiological processes that have been linked to CFS, for example, oxidative stress and mitochondrial dysfunction. Methods We studied 22 CFS patients and 13 healthy controls who underwent MRS scanning at 7 T with a voxel placed in the anterior cingulate cortex. Neurometabolite concentrations were calculated using the unsuppressed water signal as a reference. Results Compared to controls, CFS patients had lowered levels of glutathione, total creatine and myo-inositol in anterior cingulate cortex. However, when using N-acetylaspartate as a reference metabolite, only myo-inositol levels continued to be significantly lower in CFS participants. Conclusions The changes in glutathione and creatine are consistent with the presence of oxidative and energetic stress in CFS patients and are potentially remediable by nutritional intervention. A reduction in myo-inositol would be consistent with glial dysfunction. However, the relationship of the neurochemical abnormalities to the causation of CFS remains to be established, and the current findings require prospective replication in a larger sample.
spellingShingle Godlewska, BR
Williams, S
Emir, UE
Chen, C
Sharpley, AL
Goncalves, AJ
Andersson, MI
Clarke, W
Angus, B
Cowen, PJ
Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla
title Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla
title_full Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla
title_fullStr Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla
title_full_unstemmed Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla
title_short Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla
title_sort neurochemical abnormalities in chronic fatigue syndrome a pilot magnetic resonance spectroscopy study at 7 tesla
work_keys_str_mv AT godlewskabr neurochemicalabnormalitiesinchronicfatiguesyndromeapilotmagneticresonancespectroscopystudyat7tesla
AT williamss neurochemicalabnormalitiesinchronicfatiguesyndromeapilotmagneticresonancespectroscopystudyat7tesla
AT emirue neurochemicalabnormalitiesinchronicfatiguesyndromeapilotmagneticresonancespectroscopystudyat7tesla
AT chenc neurochemicalabnormalitiesinchronicfatiguesyndromeapilotmagneticresonancespectroscopystudyat7tesla
AT sharpleyal neurochemicalabnormalitiesinchronicfatiguesyndromeapilotmagneticresonancespectroscopystudyat7tesla
AT goncalvesaj neurochemicalabnormalitiesinchronicfatiguesyndromeapilotmagneticresonancespectroscopystudyat7tesla
AT anderssonmi neurochemicalabnormalitiesinchronicfatiguesyndromeapilotmagneticresonancespectroscopystudyat7tesla
AT clarkew neurochemicalabnormalitiesinchronicfatiguesyndromeapilotmagneticresonancespectroscopystudyat7tesla
AT angusb neurochemicalabnormalitiesinchronicfatiguesyndromeapilotmagneticresonancespectroscopystudyat7tesla
AT cowenpj neurochemicalabnormalitiesinchronicfatiguesyndromeapilotmagneticresonancespectroscopystudyat7tesla